Aclaris Therapeutics Inc (ACRS)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Aug 1, 2026 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Common Stock | Disposal | 12,385 | $5.20 |
| Aug 1, 2026 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Restricted Stock Units | Disposal | 36,375 | $0 |
| Aug 1, 2026 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Common Stock | Acquisition | 36,375 | n/a |
| Aug 1, 2026 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Restricted Stock Units | Acquisition | 36,375 | $0 |
| Jun 5, 2026 | MILANO, VINCENT | Director | Common Stock | Acquisition | 11,580 | n/a |
| Jun 5, 2026 | MOLINEAUX, CHRISTOPHER P. | Director | Common Stock | Acquisition | 11,580 | n/a |
| Jun 5, 2026 | HUMPHRIES, WILLIAM D. | Director | Restricted Stock Units | Disposal | 11,580 | $0 |
| Jun 5, 2026 | SCHIFF, ANDREW N | Director | Restricted Stock Units | Disposal | 11,580 | $0 |
| Jun 5, 2026 | MOLINEAUX, CHRISTOPHER P. | Director | Restricted Stock Units | Disposal | 11,580 | $0 |
| Jun 5, 2026 | GOWEN, MAXINE | Director | Common Stock | Acquisition | 11,580 | n/a |
| Jun 5, 2026 | MEHRA, ANAND | Director | Common Stock | Acquisition | 11,580 | n/a |
| Jun 5, 2026 | SCHIFF, ANDREW N | Director | Common Stock | Acquisition | 11,580 | n/a |
| Jun 5, 2026 | GOWEN, MAXINE | Director | Restricted Stock Units | Disposal | 11,580 | $0 |
| Jun 5, 2026 | MEHRA, ANAND | Director | Restricted Stock Units | Disposal | 11,580 | $0 |
| Jun 5, 2026 | HUMPHRIES, WILLIAM D. | Director | Common Stock | Acquisition | 11,580 | n/a |
| Jun 5, 2026 | MILANO, VINCENT | Director | Restricted Stock Units | Disposal | 11,580 | $0 |
| Jun 5, 2026 | HUMPHRIES, WILLIAM D. | Director | Restricted Stock Units | Acquisition | 11,580 | $0 |
| Jun 5, 2026 | SCHIFF, ANDREW N | Director | Restricted Stock Units | Acquisition | 11,580 | $0 |
| Jun 5, 2026 | MOLINEAUX, CHRISTOPHER P. | Director | Restricted Stock Units | Acquisition | 11,580 | $0 |
| Jun 5, 2026 | MILANO, VINCENT | Director | Restricted Stock Units | Acquisition | 11,580 | $0 |
| Jun 5, 2026 | MEHRA, ANAND | Director | Restricted Stock Units | Acquisition | 11,580 | $0 |
| Jun 5, 2026 | GOWEN, MAXINE | Director | Restricted Stock Units | Acquisition | 11,580 | $0 |
| Jun 4, 2026 | HUMPHRIES, WILLIAM D. | Director | Restricted Stock Units | Acquisition | 10,987 | $0 |
| Jun 4, 2026 | MOLINEAUX, CHRISTOPHER P. | Director | Stock Option (Right to Buy) | Acquisition | 42,350 | $0 |
| Jun 4, 2026 | SCHIFF, ANDREW N | Director | Restricted Stock Units | Acquisition | 10,987 | $0 |
| Jun 4, 2026 | MILANO, VINCENT | Director | Stock Option (Right to Buy) | Acquisition | 42,350 | $0 |
| Jun 4, 2026 | MOLINEAUX, CHRISTOPHER P. | Director | Restricted Stock Units | Acquisition | 10,987 | $0 |
| Jun 4, 2026 | SCHIFF, ANDREW N | Director | Stock Option (Right to Buy) | Acquisition | 42,350 | $0 |
| Jun 4, 2026 | MEHRA, ANAND | Director | Stock Option (Right to Buy) | Acquisition | 42,350 | $0 |
| Jun 4, 2026 | GOWEN, MAXINE | Director | Stock Option (Right to Buy) | Acquisition | 42,350 | $0 |
| Jun 4, 2026 | MILANO, VINCENT | Director | Restricted Stock Units | Acquisition | 10,987 | $0 |
| Jun 4, 2026 | HUMPHRIES, WILLIAM D. | Director | Stock Option (Right to Buy) | Acquisition | 42,350 | $0 |
| Jun 4, 2026 | MEHRA, ANAND | Director | Restricted Stock Units | Acquisition | 10,987 | $0 |
| Jun 4, 2026 | GOWEN, MAXINE | Director | Restricted Stock Units | Acquisition | 10,987 | $0 |
| May 1, 2026 | HALL, JESSE WAYNE | Chief Medical Officer | Common Stock | Acquisition | 36,375 | n/a |
| May 1, 2026 | HALL, JESSE WAYNE | Chief Medical Officer | Common Stock | Disposal | 9,330 | $4.41 |
| May 1, 2026 | HALL, JESSE WAYNE | Chief Medical Officer | Restricted Stock Units | Disposal | 36,375 | $0 |
| May 1, 2026 | HALL, JESSE WAYNE | Chief Medical Officer | Restricted Stock Units | Acquisition | 36,375 | $0 |
| Apr 23, 2026 | LEONARD, BRADEN MICHAEL | 10% Owner | Common Stock | Disposal | 300,000 | $4.53 |
| Mar 1, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Common Stock | Disposal | 677 | $2.87 |
| Mar 1, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Restricted Stock Units | Disposal | 2,375 | $0 |
| Mar 1, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Common Stock | Acquisition | 2,375 | n/a |
| Mar 1, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Restricted Stock Units | Acquisition | 2,375 | $0 |
| Feb 3, 2026 | WALKER, NEAL | Director, CEO | Common Stock | Acquisition | 63,475 | n/a |
| Feb 3, 2026 | LOEROP, JAMES | Chief Business Officer | Common Stock | Acquisition | 20,875 | n/a |
| Feb 3, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Restricted Stock Units | Disposal | 22,025 | $0 |
| Feb 3, 2026 | DAVIS, HUGH M. | Director, President and COO | Common Stock | Acquisition | 18,675 | n/a |
| Feb 3, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Common Stock | Acquisition | 22,025 | n/a |
| Feb 3, 2026 | WALKER, NEAL | Director, CEO | Restricted Stock Units | Disposal | 63,475 | $0 |
| Feb 3, 2026 | DAVIS, HUGH M. | Director, President and COO | Restricted Stock Units | Disposal | 18,675 | $0 |
| Feb 3, 2026 | WALKER, NEAL | Director, CEO | Common Stock | Disposal | 18,611 | $3.47 |
| Feb 3, 2026 | LOEROP, JAMES | Chief Business Officer | Common Stock | Disposal | 5,937 | $3.47 |
| Feb 3, 2026 | LOEROP, JAMES | Chief Business Officer | Restricted Stock Units | Disposal | 20,875 | $0 |
| Feb 3, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Common Stock | Disposal | 6,449 | $3.47 |
| Feb 3, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Restricted Stock Units | Acquisition | 22,025 | $0 |
| Feb 3, 2026 | LOEROP, JAMES | Chief Business Officer | Restricted Stock Units | Acquisition | 20,875 | $0 |
| Feb 3, 2026 | WALKER, NEAL | Director, CEO | Restricted Stock Units | Acquisition | 63,475 | $0 |
| Feb 3, 2026 | DAVIS, HUGH M. | Director, President and COO | Restricted Stock Units | Acquisition | 18,675 | $0 |
| Feb 2, 2026 | HALL, JESSE WAYNE | Chief Medical Officer | Restricted Stock Units | Acquisition | 98,100 | $0 |
| Feb 2, 2026 | LOEROP, JAMES | Chief Business Officer | Employee Stock Option (Right to Buy) | Acquisition | 341,900 | $0 |
| Feb 2, 2026 | HALL, JESSE WAYNE | Chief Medical Officer | Employee Stock Option (Right to Buy) | Acquisition | 343,300 | $0 |
| Feb 2, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Restricted Stock Units | Acquisition | 99,100 | $0 |
| Feb 2, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Employee Stock Option (Right to Buy) | Acquisition | 346,800 | $0 |
| Feb 2, 2026 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Employee Stock Option (Right to Buy) | Acquisition | 334,900 | $0 |
| Feb 2, 2026 | DAVIS, HUGH M. | Director, President and COO | Restricted Stock Units | Acquisition | 96,100 | $0 |
| Feb 2, 2026 | LOEROP, JAMES | Chief Business Officer | Restricted Stock Units | Acquisition | 97,700 | $0 |
| Feb 2, 2026 | WALKER, NEAL | Director, CEO | Restricted Stock Units | Acquisition | 274,800 | $0 |
| Feb 2, 2026 | KOLBECK, ROLAND WILHELM | Chief Scientific Officer | Restricted Stock Units | Acquisition | 95,700 | $0 |
| Feb 2, 2026 | DAVIS, HUGH M. | Director, President and COO | Employee Stock Option (Right to Buy) | Acquisition | 336,300 | $0 |
| Feb 2, 2026 | WALKER, NEAL | Director, CEO | Employee Stock Option (Right to Buy) | Acquisition | 961,700 | $0 |
| Feb 1, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Restricted Stock Units | Disposal | 14,750 | $0 |
| Feb 1, 2026 | LOEROP, JAMES | Chief Business Officer | Common Stock | Disposal | 10,686 | $3.51 |
| Feb 1, 2026 | LOEROP, JAMES | Chief Business Officer | Common Stock | Acquisition | 11,250 | n/a |
| Feb 1, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Common Stock | Acquisition | 14,750 | n/a |
| Feb 1, 2026 | LOEROP, JAMES | Chief Business Officer | Common Stock | Acquisition | 7,500 | n/a |
| Feb 1, 2026 | LOEROP, JAMES | Chief Business Officer | Restricted Stock Units | Disposal | 14,750 | $0 |
| Feb 1, 2026 | LOEROP, JAMES | Chief Business Officer | Resticted Stock Units | Disposal | 7,500 | $0 |
| Feb 1, 2026 | LOEROP, JAMES | Chief Business Officer | Restricted Stock Units | Disposal | 11,250 | $0 |
| Feb 1, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Common Stock | Disposal | 4,984 | $3.51 |
| Feb 1, 2026 | LOEROP, JAMES | Chief Business Officer | Common Stock | Acquisition | 14,750 | n/a |
| Feb 1, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Restricted Stock Units | Acquisition | 14,750 | $0 |
| Feb 1, 2026 | LOEROP, JAMES | Chief Business Officer | Resticted Stock Units | Acquisition | 7,500 | $0 |
| Feb 1, 2026 | LOEROP, JAMES | Chief Business Officer | Restricted Stock Units | Acquisition | 14,750 | $0 |
| Feb 1, 2026 | LOEROP, JAMES | Chief Business Officer | Restricted Stock Units | Acquisition | 11,250 | $0 |
| Jan 2, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Common Stock | Disposal | 4,461 | $2.88 |
| Jan 2, 2026 | LOEROP, JAMES | Chief Business Officer | Restricted Stock Units | Disposal | 18,150 | $0 |
| Jan 2, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Common Stock | Acquisition | 13,200 | n/a |
| Jan 2, 2026 | LOEROP, JAMES | Chief Business Officer | Common Stock | Disposal | 6,171 | $2.88 |
| Jan 2, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Restricted Stock Units | Disposal | 13,200 | $0 |
| Jan 2, 2026 | WALKER, NEAL | Director, CEO | Restricted Stock Units | Disposal | 29,150 | $0 |
| Jan 2, 2026 | LOEROP, JAMES | Chief Business Officer | Common Stock | Acquisition | 18,150 | n/a |
| Jan 2, 2026 | WALKER, NEAL | Director, CEO | Common Stock | Disposal | 9,952 | $2.88 |
| Jan 2, 2026 | WALKER, NEAL | Director, CEO | Common Stock | Acquisition | 29,150 | n/a |
| Jan 2, 2026 | LOEROP, JAMES | Chief Business Officer | Restricted Stock Units | Acquisition | 18,150 | $0 |
| Jan 2, 2026 | WALKER, NEAL | Director, CEO | Restricted Stock Units | Acquisition | 29,150 | $0 |
| Jan 2, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Restricted Stock Units | Acquisition | 13,200 | $0 |
| Jan 1, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Restricted Stock Units | Disposal | 7,500 | $0 |
| Jan 1, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Common Stock | Acquisition | 7,500 | n/a |
| Jan 1, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Common Stock | Disposal | 2,250 | $3.01 |
| Jan 1, 2026 | BALTHASER, KEVIN | Chief Financial Officer | Restricted Stock Units | Acquisition | 7,500 | $0 |
| Dec 31, 2025 | LOEROP, JAMES | Chief Business Officer | Common Stock | Disposal | 33,994 | $3.01 |
| Dec 31, 2025 | LOEROP, JAMES | Chief Business Officer | Common Stock | Acquisition | 73,750 | n/a |
| Dec 31, 2025 | BALTHASER, KEVIN | Chief Financial Officer | Restricted Stock Units | Disposal | 73,750 | $0 |
| Dec 31, 2025 | LOEROP, JAMES | Chief Business Officer | Restricted Stock Units | Disposal | 73,750 | $0 |
| Dec 31, 2025 | BALTHASER, KEVIN | Chief Financial Officer | Common Stock | Disposal | 19,934 | $3.01 |
| Dec 31, 2025 | BALTHASER, KEVIN | Chief Financial Officer | Common Stock | Acquisition | 73,750 | n/a |
| Dec 31, 2025 | BALTHASER, KEVIN | Chief Financial Officer | Restricted Stock Units | Acquisition | 73,750 | $0 |
| Dec 31, 2025 | LOEROP, JAMES | Chief Business Officer | Restricted Stock Units | Acquisition | 73,750 | $0 |
| Dec 2, 2025 | DAVIS, HUGH M. | Director, President and COO | Common Stock | Acquisition | 26,750 | n/a |
| Dec 2, 2025 | DAVIS, HUGH M. | Director, President and COO | Restricted Stock Units | Disposal | 26,750 | $0 |
| Dec 2, 2025 | DAVIS, HUGH M. | Director, President and COO | Restricted Stock Units | Acquisition | 26,750 | $0 |